Neuren Pharmaceuticals | NEU - Pre Tax Profit

Stock Price
12.42
Daily Change
-0.21 -1.66%
Monthly
-0.24%
Yearly
-3.87%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD9.86M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Clinuvel Pharmaceuticals AUD 28.8M 6.9M Jun/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Genetic Signatures AUD -2.45M 2.08M Jun/2025
Ionis Pharmaceuticals USD -93M 135M Mar/2026
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organon & Co USD -148M 391M Dec/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Starpharma Holdings AUD -2.3M 1.94M Jun/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025
Viatris USD -343M 335.1M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025